Spots Global Cancer Trial Database for gastrointestinal stromal tumor (gist)
Every month we try and update this database with for gastrointestinal stromal tumor (gist) cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Pazopanib in Imatinib Refractory or Intolerant Gastrointestinal Stromal Tumors (GIST) | NCT01391611 | Gastrointestina... | Pazopanib | 18 Years - | Stanford University | |
| Liver Transplantation for Unresectable GIST Liver Metastases | NCT04825470 | Liver Diseases Liver Cancer Liver Metastase... Liver Neoplasms Liver Mass Liver Carcinoma Liver Transplan... Liver Transplan... GIST GIST, Malignant Gastrointestina... Gastrointestina... Gastrointestina... Gastrointestina... Gastrointestina... Gastrointestina... Gastrointestina... Gastrointestina... Gastrointestina... Gastrointestina... Gastrointestina... Gastrointestina... Metastases to L... Metastatic Live... Metastasis Metastases Liver Transplan... Transplant Onco... | Liver Transplan... | 18 Years - | Hospital Universitario Virgen de la Arrixaca | |
| A Study of HQP1351 in Patients With GIST or Other Solid Tumors | NCT03594422 | Gastrointestina... Solid Tumor, Ad... | HQP1351 | 12 Years - | Ascentage Pharma Group Inc. | |
| A Study of MEK162 (Binimetinib) in Combination With Pexidartinib in Patients With Advanced Gastrointestinal Stromal Tumor (GIST) | NCT03158103 | Gastrointestina... | MEK162 Pexidartinib | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Liver Transplantation for Unresectable GIST Liver Metastases | NCT04825470 | Liver Diseases Liver Cancer Liver Metastase... Liver Neoplasms Liver Mass Liver Carcinoma Liver Transplan... Liver Transplan... GIST GIST, Malignant Gastrointestina... Gastrointestina... Gastrointestina... Gastrointestina... Gastrointestina... Gastrointestina... Gastrointestina... Gastrointestina... Gastrointestina... Gastrointestina... Gastrointestina... Gastrointestina... Metastases to L... Metastatic Live... Metastasis Metastases Liver Transplan... Transplant Onco... | Liver Transplan... | 18 Years - | Hospital Universitario Virgen de la Arrixaca | |
| A Study of MEK162 (Binimetinib) in Combination With Pexidartinib in Patients With Advanced Gastrointestinal Stromal Tumor (GIST) | NCT03158103 | Gastrointestina... | MEK162 Pexidartinib | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Circulating Cell-free Tumor DNA in the Plasma of Patients With Gastrointestinal Stromal Tumors (GIST) | NCT02443948 | Gastrointestina... | Vena puncture f... | 18 Years - | Fondazione del Piemonte per l'Oncologia | |
| Advanced Gastrointestinal Endoscopic Imaging | NCT01034670 | Gastrointestina... Gastric (Stomac... Gastrointestina... | Dual axis endos... wide field fluo... CellVizio fluorescent Pep... fluorescein indocyanine gre... | 18 Years - | Stanford University | |
| Advanced Gastrointestinal Endoscopic Imaging | NCT01034670 | Gastrointestina... Gastric (Stomac... Gastrointestina... | Dual axis endos... wide field fluo... CellVizio fluorescent Pep... fluorescein indocyanine gre... | 18 Years - | Stanford University | |
| MEK162 in Combination With Imatinib Mesylate in Patients With Untreated Advanced Gastrointestinal Stromal Tumor (GIST) | NCT01991379 | Gastrointestina... | MEK162 Imatinib Mesyla... Blood draws biopsy | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| A Combination Clinical Study of PLX3397 and Pembrolizumab To Treat Advanced Melanoma and Other Solid Tumors | NCT02452424 | Melanoma Non-small Cell ... Squamous Cell C... Gastrointestina... Ovarian Cancer | PLX3397 Pembrolizumab | 18 Years - | Daiichi Sankyo | |
| Five Year Adjuvant Imatinib Mesylate (Gleevec®) in Gastrointestinal Stromal Tumor (GIST) | NCT00867113 | Gastrointestina... | imatinib mesyla... | 18 Years - | Novartis | |
| Pazopanib in Imatinib Refractory or Intolerant Gastrointestinal Stromal Tumors (GIST) | NCT01391611 | Gastrointestina... | Pazopanib | 18 Years - | Stanford University | |
| A Retrospective Pharmacokinetics and Pharmacogenomics Research of Imatinib in Gastrointestinal Stromal Tumor Treatment | NCT03092128 | Gastrointestina... Germline Mutati... Somatic Mutatio... Plasma Concentr... | 18 Years - 80 Years | Sun Yat-sen University | ||
| Ph II of Capecitabine, Carboplatin & Bevacizumab for Gastroesophageal Junction & Gastric Carcinoma | NCT00780494 | Stomach Cancer Gastric (Stomac... Neoplasm of Car... Gastrointestina... | bevacizumab carboplatin capecitabine | 18 Years - | Stanford University | |
| A Retrospective Pharmacokinetics and Pharmacogenomics Research of Imatinib in Gastrointestinal Stromal Tumor Treatment | NCT03092128 | Gastrointestina... Germline Mutati... Somatic Mutatio... Plasma Concentr... | 18 Years - 80 Years | Sun Yat-sen University | ||
| A Study to Investigate the Safety and Efficacy of AT13387, Alone or in Combination With Imatinib, in Patients With GIST | NCT01294202 | Gastrointestina... | AT13387 and Ima... | 18 Years - | Astex Pharmaceuticals, Inc. | |
| Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma | NCT01048281 | Stomach Cancer Gastro-Esophage... Gastric (Stomac... Esophageal Canc... Gastrointestina... | Blood draw Tissue tumor bi... | 18 Years - | Stanford University | |
| Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma | NCT01048281 | Stomach Cancer Gastro-Esophage... Gastric (Stomac... Esophageal Canc... Gastrointestina... | Blood draw Tissue tumor bi... | 18 Years - | Stanford University | |
| A Phase 1 Study of Mixed Bacteria Vaccine (MBV) in Patients With Tumors Expressing NY-ESO-1 Antigen | NCT00623831 | Melanoma Sarcoma Gastrointestina... Head and Neck C... Transitional Ce... Prostate Cancer Ovarian Carcino... Esophageal Canc... Breast Cancer | Mixed bacterial... | 18 Years - | Ludwig Institute for Cancer Research | |
| Circulating Cell-free Tumor DNA in the Plasma of Patients With Gastrointestinal Stromal Tumors (GIST) | NCT02443948 | Gastrointestina... | Vena puncture f... | 18 Years - | Fondazione del Piemonte per l'Oncologia | |
| Surgery in Gastrointestinal Stromal Tumors (GISTs) for Treatment, Tumor Modeling, and Genomic Analysis | NCT04557969 | Gastric Cancer Gastric Neoplas... Gastrointestina... Gastrointestina... Gastrointestina... | 6 Years - | National Institutes of Health Clinical Center (CC) | ||
| A Study of HQP1351 in Patients With GIST or Other Solid Tumors | NCT03594422 | Gastrointestina... Solid Tumor, Ad... | HQP1351 | 12 Years - | Ascentage Pharma Group Inc. | |
| B-Receptor Signaling in Cardiomyopathy | NCT01135849 | Carcinomas Amyloidosis Anal Cancer Anemia Cholangiocarcin... Transitional Ce... Bone Marrow Tra... Bone Cancer Cancer of Brain... Breast Cancer Carcinoma of th... Endocrine Cance... Esophageal Canc... Eye Cancer Gall Bladder Ca... Gastric (Stomac... Gastrooesophage... Gastrointestina... Gynecologic Can... Head and Neck C... Hepatobiliary N... Kidney (Renal C... Leukemia Lung Cancer Hodgkin Disease Lymphoma, Non-H... Mesothelioma Multiple Myelom... Myelodysplastic... Neuroendocrine ... Myeloproliferat... Pancreatic Canc... Prostate Cancer Skin Cancer Soft Tissue Sar... Testicular Canc... Thymus Cancer Thyroid Cancer | - 40 Years | Stanford University | ||
| Endoscopic Ultrasound Radiofrequency Ablation for GISTs | NCT05453292 | Gastrointestina... | Endoscopic ultr... | 18 Years - 89 Years | Instituto Ecuatoriano de Enfermedades Digestivas | |
| Five Year Adjuvant Imatinib Mesylate (Gleevec®) in Gastrointestinal Stromal Tumor (GIST) | NCT00867113 | Gastrointestina... | imatinib mesyla... | 18 Years - | Novartis | |
| B-Receptor Signaling in Cardiomyopathy | NCT01135849 | Carcinomas Amyloidosis Anal Cancer Anemia Cholangiocarcin... Transitional Ce... Bone Marrow Tra... Bone Cancer Cancer of Brain... Breast Cancer Carcinoma of th... Endocrine Cance... Esophageal Canc... Eye Cancer Gall Bladder Ca... Gastric (Stomac... Gastrooesophage... Gastrointestina... Gynecologic Can... Head and Neck C... Hepatobiliary N... Kidney (Renal C... Leukemia Lung Cancer Hodgkin Disease Lymphoma, Non-H... Mesothelioma Multiple Myelom... Myelodysplastic... Neuroendocrine ... Myeloproliferat... Pancreatic Canc... Prostate Cancer Skin Cancer Soft Tissue Sar... Testicular Canc... Thymus Cancer Thyroid Cancer | - 40 Years | Stanford University | ||
| A Study of Nilotinib Versus Imatinib in GIST Patients | NCT00785785 | Gastrointestina... | Nilotinib (AMN1... imatinib (STI57... | 18 Years - | Novartis | |
| Unifying Advanced Treatment With Advanced Imaging | NCT03404076 | Gastrointestina... | Dual Energy CT | 18 Years - | Heidelberg University |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
